Upon a finding of patent infringement, a court shall award damages adequate to compensate for the infringement, but in no event less than a reasonable royalty for the use made of the invention by the infringer. A reasonable royalty can be determined through an analysis of what a willing licensor and a willing licensee would have bargained for during an arm’s-length, hypothetical negotiation occurring on the eve of infringement. Several approaches, along with the Georgia-Pacific factors, can provide guidance.
The market approach often utilizes comparable license agreements or similar transactions to inform upon a reasonable royalty. Economic and technological differences between the comparable agreement and the hypothetical negotiation can often be quantified by way of economic, financial, or statistical methods. Such differences can include products, technologies, suppliers, customers, time periods, and competitive environments.
The income approach considers financial benefits derived by the infringer as a result of using the patented technology. These benefits can include higher prices, increased sales quantities, or reduced costs.
The cost approach can evaluate the costs of implementing a viable non-infringing alternative that provides that is reasonably available and provides similar benefits to the patented technology.
Engagement Examples
- Calculated reasonable royalties in litigation involving video coding technology used in personal computers and gaming devices, including investigation of standard-essential patents, reasonable and non-discriminatory licensing practices, and the impact of patent licensing pools.
- In litigation involving the alleged unauthorized use of a consumer electronic patent, quantified economic damages and analyzed the economic aspects of contracts containing a license to the patent-in-suit. Also analyzed economic substitution, marketplace competition, product differentiation, sales, profitability, and other economic considerations relating to a reasonable royalty.
- Performed an analysis of damages relating to alleged infringement of patented biotechnology by quantifying reasonable royalties based on consideration of relevant licensing agreements, accused sales and profitability, and the unique contribution of the patented technology.
- Utilized statistical methods to isolate the impact of the asserted patents to the accused product’s price due to the associated performance enhancements. In certain cases, using statistical methods improves the precision of reasonable royalty calculations based on an income approach.